Skip to main content
OpenTrials

Clinical trial condition

Leiomyosarcoma

Explore clinical trials studying Leiomyosarcoma. Study availability and eligibility vary by location and protocol.

116 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Leiomyosarcoma trial results

Completed

Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma

NCT00041236

Conditions
Fibrosarcoma, Hemangiopericytoma, Malignant, Hemangiosarcoma, +25 more
Locations
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • U.Z. Gasthuisberg Leuven, Belgium
  • Aarhus University Hospital - Aarhus Sygehus - Norrebrogade Aarhus, Denmark
  • Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch Berlin, Germany
View Trial Details
Completed

Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

NCT00064220

Conditions
Fibrosarcoma, Hemangiopericytoma, Malignant, Hemangiosarcoma, +16 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Indiana University Cancer Center Indianapolis, Indiana, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Herbert Irving Comprehensive Cancer Center at Columbia University New York, United States
View Trial Details
Active, Not Recruiting

Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery

NCT02923778

Conditions
Histiocytoma, Histiocytoma, Malignant Fibrous, Leiomyosarcoma, +16 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

A Study of Rucaparib and Nivolumab in People With Leiomyosarcoma

NCT04624178

Conditions
Leiomyosarcoma, Neoplasms, Neoplasms by Histologic Type, +3 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Limited protocol activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)

NCT06088290

Conditions
Leiomyosarcoma, Neoplasms, Neoplasms by Histologic Type, +3 more
Locations
  • Mayo Clinic Hospital - Phoenix Phoenix, Arizona, United States
  • Precision NextGen Oncology & Research Center Beverly Hills, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 97 locations
View Trial Details

Related conditions